Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF (Q28165715)

https://api.crossref.org/works/10.1016/S0002-8703(03)00163-7

22 March 2024

3

Johan Herlitz

0 references

author name string

András Jánosi

1

0 references

István Czuriga

4

0 references

Michael Klibaner

5

0 references

John Wikstrand

6

0 references

Ake Hjalmarson

7

0 references

Jalal K. Ghali

2

1 reference

Europe PubMed Central

PubMed ID

14564329

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14564329

22 March 2024

MERIT-HF Study Group

8

1 reference

Europe PubMed Central

PubMed ID

14564329

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14564329

full work available at URL

22 March 2024

language of work or name

English

0 references

publication date

October 2003

0 references

https://api.elsevier.com/content/article/PII:S0002870303001637?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(03)00163-7

https://api.elsevier.com/content/article/PII:S0002870303001637?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(03)00163-7

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

22 March 2024

published in

American Heart Journal

0 references

volume

146

0 references

issue

4

0 references

page(s)

721-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Beta blockade during and after myocardial infarction: an overview of the randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Effect of carvedilol on survival in severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Göteborg Metoprolol Trial)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

MERIT-HF--description of the trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Improving the Quality of Care for Medicare Patients With Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900163-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

2

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(03)00163-7

22 March 2024

Identifiers